Concepedia

Nagalakshmi Nadiminty

NN

42

Publications

3.4K

Citations

30

H-Index

2004

Active since

Affiliations

University of California, Davis(Current)

Roswell Park Comprehensive Cancer Center

Tianjin Medical University General Hospital

University of Toledo

Tianjin Medical University

Nagalakshmi Nadiminty is an author at University of California, Davis specializing in medicine, tumor biology, and urology.

ORCID

Top concepts

Publications per year

2004–2024

42

Publications

42

Niclosamide Inhibits Androgen Receptor Variants Expression and Overcomes Enzalutamide Resistance in Castration-Resistant Prostate Cancer

Chengfei Liu, Wei Lou, Yezi Zhu et al. · Clinical Cancer Research · 2014 · 351 citations · Full text

Intracrine Androgens and AKR1C3 Activation Confer Resistance to Enzalutamide in Prostate Cancer

Chengfei Liu, Wei Lou, Yezi Zhu et al. · Cancer Research · 2015 · 239 citations · Full text

, , +11

Eugenol Causes Melanoma Growth Suppression through Inhibition of E2F1 Transcriptional Activity

Rita Ghosh, Nagalakshmi Nadiminty, James E. Fitzpatrick et al. · Journal of Biological Chemistry · 2004 · 211 citations · Full text

, , +19

MicroRNA let-7c Suppresses Androgen Receptor Expression and Activity via Regulation of Myc Expression in Prostate Cancer Cells

Nagalakshmi Nadiminty, Ramakumar Tummala, Wei Lou et al. · Journal of Biological Chemistry · 2011 · 183 citations · Full text

NF-κB2/p52 Induces Resistance to Enzalutamide in Prostate Cancer: Role of Androgen Receptor and Its Variants

Nagalakshmi Nadiminty, Ramakumar Tummala, Chengfei Liu et al. · Molecular Cancer Therapeutics · 2013 · 182 citations · Full text

Rows per page

1–5 of 42